
As highlighted in Thomas Goetz's new Wired article "Sergey's Search," 23andMe's innovative web-based research platform is pushing Parkinson's disease research ahead at an unprecedented pace. With our database clocking in at 50,000 genotyped customers—a number that grows everyday—we're poised to make [...]








